We also wanted to establish the association between the studied polymorphisms of the XPC, XPD, XPF, and XPG genes and the JAK2, CALR driver mutations and to identify possible predictors in the appearance of myeloproliferative neoplasms. Here, ERCC2 is linked to myeloproliferative disorder.